Latest news
Lucid's EsoGuard Is the Only Esophageal Precancer Test Meeting Coverage Criteria - Stock TitanStock Titan · Wed, 05 Aug 2026 12:46:00 GMTLucid Diagnostics Secures Commercial Coverage Policy Spanning Multiple Health Plans for its EsoGuard® Esophageal DNA Test - Yahoo FinanceYahoo Finance · Wed, 05 Aug 2026 12:36:00 GMTLucid Diagnostics Sets Boston Fireside Chat and Virtual Meetings - Stock TitanStock Titan · Tue, 04 Aug 2026 12:30:00 GMTLucid Diagnostics to Participate in Upcoming Investor Conferences - SahmSahm · Tue, 04 Aug 2026 07:00:00 GMTProfusa Announces Signing of Option Agreement for the Acquisition of a Commercial Stage Diagnostics Company, G3 Vision Labs - The Manila TimesThe Manila Times · Fri, 31 Jul 2026 21:28:51 GMTLucid Diagnostics to Hold Second Quarter 2026 Business Update Conference Call and Webcast on August 13, 2026 - BioSpaceBioSpace · Thu, 30 Jul 2026 07:00:00 GMTLucid Diagnostics CEO and CFO to Discuss Operations Aug. 13 - Stock TitanStock Titan · Thu, 30 Jul 2026 07:00:00 GMTProfusa Announces Key Management Changes and Signing of - GlobeNewswireGlobeNewswire · Mon, 27 Jul 2026 10:00:00 GMT